Voronoi Inc.
www.voronoi.ioVORONOI, a leading biotech in South Korea EGFR-Exon20Ins Lisenced out to ORIC Parmaceuticals in 2020 RET-Fusion Lisenced out to Inno.N in 2021 Anticipated upcoming IPO on KOSDAQ for 4Q, 2021
Read moreVORONOI, a leading biotech in South Korea EGFR-Exon20Ins Lisenced out to ORIC Parmaceuticals in 2020 RET-Fusion Lisenced out to Inno.N in 2021 Anticipated upcoming IPO on KOSDAQ for 4Q, 2021
Read moreEmployees statistics
View all employeesPotential Decision Makers
Chief Technical Officer
Email ****** @****.comPhone (***) ****-****Head of A.I. Lab.
Email ****** @****.comPhone (***) ****-****
Technologies
(17)
Reach decision makers at Voronoi Inc.
Free credits every month!
Voronoi Inc. FAQ
Incheon, South Korea
Biotechnology Research